Shareholding disclosure

Exane Derivatives SNC

Declared position

Threshold

Fell below threshold

Timeline

Published

30.05.2020

Transaction

25.05.2020

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAK5S00027

Beneficial owner

Exane Derivatives SNC

Declared address

Exane Derivatives SNC, 75002 Paris

vente de titres

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Exane Derivatives SNC

Swissquote Group Holding Ltd30.05.2020TAK5S00027

Disclosure summary

Exane Derivatives SNC disclosed a holding in Swissquote Group Holding Ltd that fell below the publication threshold, published by SIX Exchange Regulation on 30.05.2020, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Exane Derivatives SNC disclosed a holding in Swissquote Group Holding Ltd, published on 30.05.2020.

Publication date30.05.2020

Transaction date25.05.2020

Issuing companySwissquote Group Holding Ltd

Beneficial ownerExane Derivatives SNC

Declared addressExane Derivatives SNC, 75002 Paris

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAK5S00027

Conditions

vente de titres

Source: SIX Exchange Regulation · Publication date: 30.05.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open